1. Antman, E. M., Stone, P. H., Muller, J. E. and Braunwald, E., Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects.Ann. Intern. Med., 93, 875–885 (1980).
2. Baker, K. J., Binding of sulfobromophthalein (BSP) and indocyanine green (ICG) to plasma α1-lipoproteins.Proc. Soc. Exp. Biol. Med., 122, 957–963 (1966).
3. Bauer, L. A., Stenwall, M., Horn, J. R., Davis, R., Opheim, K. and Greene, L., Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy.J. Clin. Pharmacol., 40, 239–242 (1986).
4. Bourassa, M. G., Cote, P., Theroux, P., Tubau, J. F., Genain, C. and Waters, D. D., Hemodynamics and coronary flow following diltiazem administration in anesthetized dogs and in humans.Chest, 78, 224–230 (1980).
5. Caesar, J., Shaldon, S., Chaindussi, L., Guevara, L. and Sherlock, S., The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.Clin. Sci. 21, 43–57 (1961).